ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Oasmia Pharmaceuticals AB

Oasmia Pharmaceuticals AB (OASM)

1.55
0.00
(0.00%)
Closed 26 June 6:00AM
0.00
0.00
(0.00%)

Income Statement

Balance Sheet

Cash Flow

Quarter End Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
SEK (SEK)SEK (SEK)SEK (SEK)SEK (SEK)SEK (SEK)SEK (SEK)SEK (SEK)SEK (SEK)
Total Revenue 1.69M-1.3M2.91M1.68M1.02M264k1.03M7.21M
Operating Income -26.33M-36.98M-69.54M-31.04M-21.54M-28.84M-16.57M-65.23M
Pre Tax Income -26.46M-38.51M-71.68M-30.03M-20.43M-28.17M-15.78M-64.36M
Net Income -26.46M-38.51M-71.68M-30.03M-20.43M-28.17M-15.78M-64.36M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -26.33M-36.98M-69.54M-31.04M-21.54M-28.84M-16.57M-65.23M
EBITDA -19.07M-29.72M-18.68M-21.94M-17.63M-25.17M-12.88M-19.12M
Year End 31 December 2023 20172018201920202020202120222023
SEK (SEK)SEK (SEK)SEK (SEK)SEK (SEK)SEK (SEK)SEK (SEK)SEK (SEK)SEK (SEK)
Total Revenue 390k4.77M2.22M201.95M2.76M68.48M4.68M9.52M
Operating Income -140.68M-103.24M-151.33M-30.41M-131.7M-128.84M-364.35M-132.17M
Pre Tax Income -160.24M-118.01M-169.06M-43.36M-140.27M-132.72M-365.72M-128.74M
Net Income -160.24M-118.01M-201.89M-10.53M-140.27M-132.72M-365.72M-128.74M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) -1.271-0.669-0.898-0.023-0.313-0.296-0.68-0.239
EBIT -140.68M-103.24M-151.33M-30.41M-131.7M-128.84M-364.35M-132.17M
EBITDA -136.18M-98.45M-119.74M-10.38M-102.77M-99.97M-99.19M-74.8M

Your Recent History

Delayed Upgrade Clock